⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ovarian adenocarcinoma

Every month we try and update this database with for ovarian adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer SurvivorsNCT03641287
Ovarian Cancer
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Adenoca...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Primary Periton...
Exercise Counse...
Aerobic Exercis...
Physiological S...
Quality-of-Life...
Questionnaire A...
Best Practice
18 Years - University of Washington
The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer SurvivorsNCT03641287
Ovarian Cancer
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Adenoca...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Primary Periton...
Exercise Counse...
Aerobic Exercis...
Physiological S...
Quality-of-Life...
Questionnaire A...
Best Practice
18 Years - University of Washington
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerNCT05451849
Mesothelioma
Mesotheliomas P...
Mesothelioma, M...
Mesothelioma Pe...
Ovarian Cancer
Ovarian Serous ...
Pancreatic Canc...
Pancreatic Aden...
Colorectal Canc...
Triple Negative...
TNBC - Triple-N...
Ovarian Adenoca...
Pancreatic Neop...
Colorectal Neop...
Ovarian Neoplas...
Cholangiocarcin...
Non Small Cell ...
TC-510
Fludarabine
Cyclophosphamid...
18 Years - TCR2 Therapeutics
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT02923739
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Adenoca...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Emactuzumab
Laboratory Biom...
Paclitaxel
Pharmacological...
18 Years - M.D. Anderson Cancer Center
CINSARC Genomic Signature as Predictor of Resectability of Ovarian AdenocarcinomaNCT04248231
Ovarian Adenoca...
CINSARC signatu...
18 Years - Institut Claudius Regaud
A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian CancerNCT03281681
Ovarian Cancer
VAL-083, Dianhy...
18 Years - Kintara Therapeutics, Inc.
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerNCT05451849
Mesothelioma
Mesotheliomas P...
Mesothelioma, M...
Mesothelioma Pe...
Ovarian Cancer
Ovarian Serous ...
Pancreatic Canc...
Pancreatic Aden...
Colorectal Canc...
Triple Negative...
TNBC - Triple-N...
Ovarian Adenoca...
Pancreatic Neop...
Colorectal Neop...
Ovarian Neoplas...
Cholangiocarcin...
Non Small Cell ...
TC-510
Fludarabine
Cyclophosphamid...
18 Years - TCR2 Therapeutics
Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNCT02834013
Acinar Cell Car...
Adenoid Cystic ...
Adrenal Cortica...
Adrenal Gland P...
Anal Canal Neur...
Anal Canal Undi...
Angiosarcoma
Apocrine Neopla...
Appendix Mucino...
Bartholin Gland...
Basal Cell Carc...
Bladder Adenoca...
Breast Metaplas...
Cervical Adenoc...
Cholangiocarcin...
Chordoma
Colorectal Squa...
Desmoid Fibroma...
Endometrial Tra...
Endometrioid Ad...
Esophageal Neur...
Esophageal Undi...
Extrahepatic Bi...
Extramammary Pa...
Fallopian Tube ...
Fallopian Tube ...
Fibromyxoid Tum...
Gallbladder Car...
Gastric Neuroen...
Gastric Squamou...
Gastric Undiffe...
Gastrointestina...
Gestational Tro...
Giant Cell Carc...
Human Papilloma...
Intestinal Neur...
Intrahepatic Ch...
Lung Neuroendoc...
Lung Sarcomatoi...
Major Salivary ...
Malignant Odont...
Malignant Perip...
Malignant Solid...
Malignant Testi...
Metastatic Mali...
Metastatic Pitu...
Minimally Invas...
Mixed Mesoderma...
Mucinous Adenoc...
Mucinous Cystad...
Nasal Cavity Ad...
Nasal Cavity Ca...
Nasopharyngeal ...
Nasopharyngeal ...
Nasopharyngeal ...
Oral Cavity Car...
Oropharyngeal U...
Ovarian Adenoca...
Ovarian Germ Ce...
Ovarian Mucinou...
Ovarian Squamou...
Ovarian Transit...
Pancreatic Acin...
Pancreatic Neur...
Paraganglioma
Paranasal Sinus...
Paranasal Sinus...
Parathyroid Gla...
PEComa
Penile Squamous...
Peritoneal Meso...
Placental Chori...
Primary Periton...
Pseudomyxoma Pe...
Rare Disorder
Scrotal Squamou...
Seminal Vesicle...
Seminoma
Serous Cystaden...
Small Intestina...
Small Intestina...
Spindle Cell Ne...
Teratoma With S...
Testicular Non-...
Thyroid Gland C...
Tracheal Carcin...
Transitional Ce...
Ureter Adenocar...
Ureter Squamous...
Urethral Adenoc...
Urethral Squamo...
Vaginal Adenoca...
Vaginal Squamou...
Vulvar Carcinom...
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Ipilimumab
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian CancerNCT03281681
Ovarian Cancer
VAL-083, Dianhy...
18 Years - Kintara Therapeutics, Inc.
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT02923739
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Adenoca...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Emactuzumab
Laboratory Biom...
Paclitaxel
Pharmacological...
18 Years - M.D. Anderson Cancer Center
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving ChemotherapyNCT00899093
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Ovarian Adenoca...
Primary Periton...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Cytology Specim...
Laboratory Biom...
18 Years - GOG Foundation
A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian CancerNCT03281681
Ovarian Cancer
VAL-083, Dianhy...
18 Years - Kintara Therapeutics, Inc.
Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary AdenocarcinomaNCT02217956
Ovarian Adenoca...
Fallopian Tube ...
Primary Periton...
Cisplatin
Bevacizumab
18 Years - 65 YearsGustave Roussy, Cancer Campus, Grand Paris
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)NCT05001282
Ovarian Cancer
Ovarian Neoplas...
Ovarian Carcino...
Endometrial Can...
Ovary Cancer
Ovary Neoplasm
Ovary Disease
Ovary Metastasi...
Ovarian Disease...
Ovarian Cancer ...
Ovarian Epithel...
Ovarian Adenoca...
Ovarian Serous ...
Ovarian Neoplas...
Ovarian Cancer ...
Endometrial Dis...
Endometrial Ade...
Endometrial Car...
Endometrial Cle...
Endometrioid Ad...
Endometrial Neo...
Endometrial Can...
Endometrioid Tu...
Fallopian Tube ...
Peritoneal Canc...
ELU001
18 Years - Elucida Oncology
A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian CancerNCT03281681
Ovarian Cancer
VAL-083, Dianhy...
18 Years - Kintara Therapeutics, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: